Molecular formula: | C24H29N5O3 |
Average mass: | 435.528 |
Monoisotopic mass: | 435.227040 |
ChemSpider ID: | 4447678 |
1 of 1 defined stereocentres
Wikipedia
(2R)-3-methyl-2-(N-{[2′-(1H-1,2,3,4-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl}pentanamido)butanoic acid
(R)-N-Valeryl-N-([2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl)valine
137862-87-4
[RN]D-valine, N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
D-Valine, N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
[ACD/Index Name]D-Valsartan
MFCD18252868
[MDL number]N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-D-valine
N-pentanoyl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-D-valine
N-Pentanoyl-N-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-D-valin
[German]
[ACD/IUPAC Name]N-Pentanoyl-N-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-D-valine
[ACD/IUPAC Name]N-Pentanoyl-N-{[2′-(2H-tétrazol-5-yl)-4-biphénylyl]méthyl}-D-valine
[French]
[ACD/IUPAC Name]N-pentanoyl-N-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-D-valine
N-VALERYL-N-{[2′-(1HTETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-D-VALINE(ent-Valsartan)
(2R)-3-methyl-2-(N-{[2′-(2H-1,2,3,4-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl}pentanamido)butanoic acid
(2R)-3-methyl-2-[1-oxopentyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(2R)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
(2R)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(2R)-3-methyl-2-[pentanoyl-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(2R)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(2R)-3-Methyl-2-[pentanoyl[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic Acid (Valsartan (R)-Enantiomer)
(r)-2-(n-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
(R)-2-(N-((2′-(1H-Tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
(R)-3-Methyl-2-{pentanoyl-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
(R)-[N-valeryl-N-([2′-(1H-tetrazole-5-yl)biphen-4-yl]methyl)valine)
(R)-Valsartan
1089736-73-1
[RN][(R-N-valeryl-N-([2′-(1H-tetrazole-5-yl)biphen-4-yl]methyl)valine)
AC1NR4SZ
DSSTox_CID_3735
ENT VALSARTAN
ent-valsartan
N-((2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-N-pentanoyl-D-valine
N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
valsartan r-enantiomer
VALSARTAN, D-
VALSARTAN-D9